Just Other Articles

Success is easy to measure. It can be quantified in terms of profit, cash flow, and wealt

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

h.

Failure is more subtle.

Of course, some failures can be quantified, such as the valu

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

of a lost sale or the cost of a project delay.

Since such failures are easy to measure,

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

most people focus on them.

But there is a type of failure that people ignore. It has hu

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e costs. And it defies measurement.

It’s the future you could have had if you had made t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e correct decisions.

Before you become depressed by tallying a lost fortune, realize tha

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

t some of this can be easily fixed by holding effective meetings.

With a bad meeting, th

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

re are no results. That means there are no plans, no solutions, no agreements. Thus your

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

usiness stays stuck with whatever you had before the meeting. And that represents a much

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

larger loss than the time and payroll wasted on the bad meeting.

Imagine what your busin

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ss could achieve with a creative plan for increasing revenue.

Imagine what your staff co

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ld do with solutions to the problems that hinder their productivity.

Imagine what you co

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

uld do with an agreement to support your vision for your business.

With a bad meeting, y

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

u have none of these. And the cost of not having these is everything that your future wit

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

them could contain.

This is why your next meeting is more than just a few hours spent i

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

n a conference room.

It’s your future.

So, do more than host a party where everyone tal

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

s about anything and everything.

Set a specific goal. Prepare an agenda. Invite those wh

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

can help. Involve all of the attendees. Use group process systems. And document the resu

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

lts.

In short, run the meeting like a business that earns a profit on your investment of

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

time and resources.

And when it matters, hire a professional meeting facilitator to help

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/20779/justotherarticles-Worst-Kind-of-Failure.html">Worst Kind of Failure</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/20779/justotherarticles-Worst-Kind-of-Failure.html]Worst Kind of Failure[/url]

Do you take business actions based upon what you think, what conventional wisdom dictates or what you truly know based upon validated information? Using assessments is necessary to receive an accurate picture of what is happening within the organization.

Nursing Uniforms have been a hot ticket item as of late. With the recent surge within the nursing profession, uniform sales have also been on the rise

Will it take a lot of money to start a mobile car wash business? This is the first question people think to themselves when considering going into business washing peoples cars at homes and office buildings.

Tags

Links

Just Other Articles - Worst Kind of Failure

Related Articles: